ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC10226-1mg |
|
778649-18-6 |
Butyrolactone 3
|
0 | C9H12O4 | |
GC10225-10mM (in 1mL DMSO) |
|
1110813-31-4 |
Dacomitinib (PF299804, PF299)
|
0 | C24H25ClFN5O2 | |
GC10225-25mg |
|
1110813-31-4 |
Dacomitinib (PF299804, PF299)
|
0 | C24H25ClFN5O2 | |
GC10225-5mg |
|
1110813-31-4 |
Dacomitinib (PF299804, PF299)
|
0 | C24H25ClFN5O2 | |
GC10224-10mM (in 1mL DMSO) |
|
1722-62-9 |
Mepivacaine HCl
|
0 | C15H22N2O.HCl | |
GC10224-50mg |
|
1722-62-9 |
Mepivacaine HCl
|
0 | C15H22N2O.HCl | |
GC10223-50mg |
|
171009-07-7 |
CCT018159
|
0 | C20H20N2O4 | |
GC10223-10mg |
|
171009-07-7 |
CCT018159
|
0 | C20H20N2O4 | |
GC10223-5mg |
|
171009-07-7 |
CCT018159
|
0 | C20H20N2O4 | |
GC10222-10mM (in 1mL DMSO) |
|
1038395-65-1 |
KX2-391 dihydrochloride
|
0 | C26H31Cl2N3O3 | |
GC10222-250mg |
|
1038395-65-1 |
KX2-391 dihydrochloride
|
0 | C26H31Cl2N3O3 | |
GC10222-50mg |
|
1038395-65-1 |
KX2-391 dihydrochloride
|
0 | C26H31Cl2N3O3 | |
GC10222-10mg |
|
1038395-65-1 |
KX2-391 dihydrochloride
|
0 | C26H31Cl2N3O3 | |
GC10222-5mg |
|
1038395-65-1 |
KX2-391 dihydrochloride
|
0 | C26H31Cl2N3O3 | |
GC10221-50mg |
|
484-17-3 |
9-Phenanthrol
|
0 | C14H10O | |
GC10220-100mg |
|
1005780-62-0 |
TAK-593
|
0 | C23H23N7O3 | |
GC10220-50mg |
|
1005780-62-0 |
TAK-593
|
0 | C23H23N7O3 | |
GC10220-10mg |
|
1005780-62-0 |
TAK-593
|
0 | C23H23N7O3 | |
GC10220-5mg |
|
1005780-62-0 |
TAK-593
|
0 | C23H23N7O3 | |
GC10219-50mg |
|
102394-31-0 |
AF-DX 116
|
0 | C24H31N5O2 | |